Cite
APA Citation
Gregory, G., Walker, P., Mahadevan, D., Wang, D., Chang, J., Hernandez‐Ilizaliturri, F., Klein, A., Rybka, W., Wagner‐Johnston, N., Escobar, C., Pagel, J., Mohrbacher, A., Opat, S., Shortt, J., Ma, H., Gwo, J., Farooqui, M., & Quach, H. (n.d.). aNTITUMOR ACTIVITY OF PEMBROLIZUMAB PLUS DINACICLIB IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA: THE PHASE 1B KEYNOTE‐155 STUDY. Hematological oncology, 37, 328–329. http://access.bl.uk/ark:/81055/vdc_100086191805.0x00003b